Skip to main content

Cutaneous T-cell Lymphoma

Question for Department of Health and Social Care

UIN 132917, tabled on 30 December 2020

To ask the Secretary of State for Health and Social Care, with reference to the UK Strategy for Rare Diseases: 2020 update to the Implementation Plan for England, published on 26 February 2020, what progress his Department has made on providing the best quality of evidence based care and treatment for people living with Cutaneous T-cell lymphoma.

Answered on

14 January 2021

NHS England and NHS Improvement is continuing to work with providers of specialised services to deliver best-quality evidence-based care and treatment for patient living with rare cancers and has continued to work through the objectives set out in the United Kingdom Strategy for Rare Diseases.

NHS England has contributed to the development of the UK Rare Disease Framework, which was published on 9 January and will work with other stakeholders in England to develop an action plan to implement the Framework.

Answered by

Department of Health and Social Care